clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04691986 |
P17 | country | United States of America | Q30 |
P582 | end time | 2025-03-31 | |
P4135 | maximum age | 85 | |
P1050 | medical condition | atrophy | Q194520 |
P2899 | minimum age | 65 | |
P1132 | number of participants | 144 | |
P4844 | research intervention | vitamin B | Q183206 |
niacinamide | Q192423 | ||
hypolipidemic | Q955332 | ||
mechanism of action | Q3271540 | ||
vasodilator agent | Q4008956 | ||
nicotinic acid | Q7030579 | ||
antimetabolite | Q50429865 | ||
P8005 | research subject recruitment status | recruiting | Q76649708 |
P1813 | short name | NR-VET | |
P580 | start time | 2021-10-18 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans |
Search more.